Menactra: Clinical Trials

4 trials of Menactra, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 34Completed 4
Phase 21Completed 1

Follow Menactra: new trials by email Literature Review of Menactra trials Research Report on Menactra

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial to Evaluate the Immunogenicity and Safety of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) in Adults Aged 18 to 55 Years
batch 1 of Group ACYW135 Meningococcal Conjugate Vaccine (CRM197) (MCV4), batch 2 of MCV4, batch 3 of MCV4 - Meningococcal Meningitis
Phase 3CompletedCanSino Biologics Inc.14802024-03-202026-08-06
Study to Evaluate the Lot to Lot Consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine and to Compare Its Safety and Immunogenicity With That of Licensed Meningococcal ACWY Vaccine Menactra® in Healthy Individuals 18-85 Years of Age
NmCV-5, Menactra - Vaccine for Meningococcal Disease
Phase 2 / Phase 3CompletedSerum Institute of India Pvt. Ltd.16402019-12-272021-09-08
Study to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)
NmCV-5, Menactra - Meningococcal Meningitis
Phase 3CompletedSerum Institute of India Pvt. Ltd.18002019-08-202021-07-27
Safety and Immune Response of Novartis of MenACWY Conjugate Vaccine When Given to Healthy Children
MenACWY-CRM, Licensed meningococcal ACWY vaccine - Meningococcal Infections
Phase 3CompletedNovartis Vaccines29072008-03-012016-02-15

Conditions studied

Meningitis, Meningococcal (2)  ·  Meningitis (1)  ·  Meningococcal Infections (1)

Sponsors

Serum Institute of India Pvt. Ltd. (2)  ·  CanSino Biologics Inc. (1)  ·  Novartis Vaccines (1)

Countries

Canada (1)  ·  India (1)  ·  Indonesia (1)  ·  Mali (1)  ·  The Gambia (1)  ·  United States (1)

Top investigators

Dr Prasad Kulkarni, MD (1)  ·  Isti Suharjanti, Dr (1)

Results publications

PMID 20943209, PMID 37224196, PMID 37256991, PMID 37256992, PMID 39521012